Trial intelligence / Profile preview

Transversus abdominis plane block with liposomal bupivacaine vs ropivacaine in colorectal surgery

ChiCTR2400082171Phase 4Recruiting

Sponsor
Henan Cancer Hospital
Start
Mar 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of bupivacaine in Postoperative gastrointestinal dysfunction (POGD) and postoperative pain (2 arms), sponsored by Henan Cancer Hospital. Primary endpoint: First postoperative exhaust time. Started Mar 2024; status: recruiting.

02

Drugs

bupivacaine
03

Conditions

Postoperative gastrointestinal dysfunction (POGD)postoperative pain

Beyond the preview

Go deeper on ChiCTR2400082171.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2400082171.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call